Naomi Whittel
Founder, Naomi Wellbeauty · NYT Bestselling Author · Medical Expert Review
Dr. Vincenzo Mollace, MD
Professor of Cardiology, Magna Graecia University · Lead author, BergAmore® clinical trials · Multiple bergamot liver studies 2015–2025
Bergamot polyphenols have demonstrated meaningful effects on fatty liver disease in multiple studies, including a 2020 randomized controlled trial in which bergamot supplementation reduced liver fat content by 44% vs. 26% in placebo at just 12 weeks. Bergamot was show to stimulate autophagy (the liver’s fat-clearance process) and reduced inflammatory signaling.
Fatty liver disease has quietly become the most common liver disorder in Western countries, affecting an estimated 25-30% of the global adult population. Most people who have it have no idea they have a fatty liver, there are no symptoms in its early stages. The liver simply accumulates fat gradually, over years of metabolic imbalance.
A growing body of research is identifying specific natural compounds that can reverse the earliest stages of fatty liver disease by targeting the metabolic pathways that cause fat to accumulate in hepatocytes in the first place. Bergamot polyphenols are emerging as one of the most promising compounds in this area. Dr. Vincenzo Mollace’s research group at Magna Graecia University in Calabria, Italy has published multiple studies specifically investigating bergamot’s effects on liver fat.
|
25–30% of Western adults have NAFLD/MASLD Most have no symptoms and no diagnosis |
MASLD Newly renamed from NAFLD in 2023 Metabolic-Associated Steatotic Liver Disease |
2020 Randomised controlled trial Bergamot reduced liver fat by 44% vs 26% in placebo (Ferro et al.) |
What is fatty liver disease? NAFLD, MASLD, and the metabolic connection
Fatty liver disease (now officially called MASLD - Metabolic-Associated Steatotic Liver Disease) is defined as the accumulation of fat in more than 5% of liver cells in people who do not drink excessive amounts of alcohol. It is the liver’s equivalent of the metabolic imbalances that drive high cholesterol and type 2 diabetes.
The old name, NAFLD (Non-Alcoholic Fatty Liver Disease), described what the condition was not. The new name, MASLD, describes what it is: a metabolic condition, driven by the same cluster of factors that cause elevated triglycerides, insulin resistance, and central obesity. If you have metabolic syndrome, your risk of MASLD is dramatically elevated. Conversely, if you have elevated triglycerides and cholesterol, there is a meaningful probability you also have some degree of liver fat accumulation.
The spectrum of liver disease
At the earliest stage of fatty liver, liver cells simply accumulate fat droplets (simple steatosis). This stage is reversible with metabolic intervention but without improvement, inflammation will occur.
A steady progression of fibrosis (scarring) potentially develops into a more severe of cirrhosis. The urgency of addressing fatty liver lies in this progression, because the early stage is silent and by the time symptoms appear significant damage may occur.
Why cholesterol and fatty liver are linked
The liver is the primary organ for cholesterol synthesis, triglyceride packaging, and lipid regulation. When the liver accumulates fat, its ability to manage all three processes is impaired. This is why elevated triglycerides and low HDL are both diagnostic criteria for metabolic syndrome and warning signs for underlying MASLD. Addressing the liver’s metabolic environment is increasingly recognized as a more complete approach to cardiovascular and metabolic health.
This is the deeper reason why bergamot’s effects on liver metabolism are significant. Its polyphenols do not just reduce cholesterol in the blood, they target the liver directly to modulate the metabolic processes that drive both dyslipidaemia and hepatic fat accumulation simultaneously.
How Bergamot Polyphenols Target Fatty Liver
Research by Dr. Mollace’s group and colleagues has identified several distinct mechanisms by which bergamot polyphenols act on the liver. These mechanisms explain why bergamot’s effects extend beyond cholesterol to liver fat specifically.
|
Lipogenesis suppression - the primary mechanism Bergamot polyphenols dramatically suppress de novo lipogenesis, the metabolic process by which the liver converts excess dietary carbohydrates and fats into new fat. The 2024 Parafati study found this was the dominant liver-specific effect of bergamot. In simple terms, bergamot tells the liver to stop making more fat. |
Lipophagy stimulation - fat clearance Bergamot stimulates lipophagy, the process by which liver cells self-digest and clear accumulated fat droplets through autophagy. A 2015 study (Parafati et al.) was the first to identify this mechanism showing that bergamot prevented NAFLD in an animal model specifically by activating lipophagy in hepatocytes. |
|
AMPK activation - the metabolic master switch AMPK (AMP-activated protein kinase) is a cellular energy sensor that stimulates fat burning and suppresses fat synthesis. AMPK activation explains why bergamot simultaneously improves cholesterol, triglycerides, and hepatic fat. |
Anti-inflammatory action on liver tissue A 2018 study found that bergamot supplementation significantly reduced inflammatory markers in liver tissue, supporting recovery from NASH-stage disease. |
The convergence of these four mechanisms gives bergamot a comprehensive effect on liver fat that few natural compounds match.
The Published Evidence: 4 Key Studies
The following studies represent the highest-quality evidence for bergamot’s effects on liver fat and MASLD/NAFLD.
1. Ferro et al. 2020 • RCT • Front Endocrinol
Double-blind randomised controlled trial. 52 non-diabetic adults over 50 with liver steatosis. 12-week bergamot + wild cardoon nutraceutical. The CAP score (liver fat measurement by elastography) fell 44% in the treatment group vs 26% in placebo. Effect was statistically significant in patients over 50 and in women. Authors described the formulation as potentially ‘cornerstone treatment’ for liver steatosis.
Ferro Y, et al. Front Endocrinol. 2020;11:494. doi:10.3389/fendo.2020.00494. PMC7431622
2. Parafati et al. 2024 • Antioxidants
Key mechanistic study from Dr. Mollace’s group identified dramatic suppression of de novo lipogenesis as the primary liver-specific effect of bergamot flavonoids in fatty liver disease.
Parafati M, et al. Antioxidants. 2024;13(7):766. doi:10.3390/antiox13070766. PMC11273501
3. Rillo et al. 2025 • Nutrients • Nov 2025
The most recent bergamot liver study monitored a 15-week cafeteria diet induced fat accumulation and upregulation of lipogenesis genes. Bergamot supplementation reversed these changes, reducing hepatic lipid droplet accumulation and boosting autophagy, confirming the lipogenesis-suppression mechanism across species.
Riillo C, et al. Nutrients. 2025;17(23):3684. doi:10.3390/nu17233684. PMC12693897
4. Parafati et al. 2018 • Nutrients • NASH model
Tested bergamot as a therapeutic agent in rats with established NASH (the inflammatory stage of fatty liver). Animals switched to a normal diet supplemented with bergamot showed significantly faster recovery, with marked reductions in liver inflammation markers.
Parafati M, et al. Nutrients. 2018;10(11):1604. doi:10.3390/nu10111604. PMC6267059
Why bergamot addresses both MASLD and metabolic syndrome
MASLD and metabolic syndrome are two presentations of the same underlying metabolic dysfunction. Elevated triglycerides, low HDL, and insulin resistance are also the primary drivers of liver fat accumulation in MASLD.
The implication for supplementation is significant: a compound that addresses the metabolic drivers of high cholesterol and triglycerides at the liver is simultaneously addressing the metabolic environment that drives liver fat accumulation. Bergamot’s documented effects on the lipid panel and its documented effects on liver fat are the same mechanism observed from two different vantage points.
Who is most at risk for MASLD?
Risk factors for MASLD include: body mass index above 25, elevated triglycerides (above 150 mg/dL), low HDL cholesterol, fasting blood glucose above 100 mg/dL, high blood pressure, and a diet high in refined carbohydrates and fructose. If three or more of these criteria apply to you, the probability of having some degree of liver fat accumulation is high and you may benefit from both lipid management and liver-targeted metabolic support.
Bergamot and Fatty Liver: Dietary Context Matters
Bergamot should not be used as a treatment that compensates for poor diet, but as a metabolic support that amplifies and accelerates the benefits of dietary improvements. The most evidence-based approach to addressing MASLD through supplementation:
1. Reduce refined carbohydrates and fructose. Reducing the driver while suppressing the pathway is more effective than either alone.
2. Increase fiber intake. Soluble fiber from vegetables, legumes, and whole grains supports the gut microbiome and reduces hepatic fat accumulation through short-chain fatty acid production. The 2025 Riillo study found bergamot also boosted short-chain fatty acid production in the gut.
3. Supplement with bergamot at 650-1000mg daily
4. Consider bergamot + berberine for combined AMPK support.
Frequently asked questions
Does bergamot help with fatty liver?
Yes - multiple studies have demonstrated beneficial effects of bergamot polyphenols on fatty liver (NAFLD/MASLD). A 2020 randomized controlled trial found bergamot supplementation reduced liver fat content by 44% over 12 weeks compared to 26% in placebo.
What is MASLD, and how is it different from NAFLD?
MASLD (Metabolic-Associated Steatotic Liver Disease) is the new official name for what was previously called NAFLD (Non-Alcoholic Fatty Liver Disease), following a 2023 international consensus. The rename reflects the understanding that this is fundamentally a metabolic condition driven by the same factors as high cholesterol, triglycerides, and blood sugar. The conditions are the same; MASLD is simply the updated term.
What dose of bergamot is best for liver health?
The published clinical studies on bergamot and liver health used doses ranging from 500mg to 1300mg of bergamot polyphenol fraction daily.
Can bergamot reverse fatty liver?
The 2020 Ferro RCT demonstrated statistically significant reductions in liver fat content over 12 weeks. The studies to date have been conducted in early-stage fatty liver (simple steatosis and early NASH). Early-stage fatty liver is highly responsive to metabolic intervention; advanced disease requires medical management.
Does bergamot work better with berberine for fatty liver?
Bergamot and berberine activate the same AMPK pathway through complementary mechanisms. Bergamot primarily through its polyphenols’ effects on hepatic lipid metabolism, berberine primarily through its effects on glucose metabolism and insulin sensitivity. Both have independent evidence for improving the metabolic markers associated with fatty liver. The combination addresses the condition from two angles simultaneously and is supported by the mechanism of action.
Are there any side effects of bergamot supplements for liver health?
Bergamot has been well-tolerated across all published clinical studies. There are no documented adverse liver effects. As with any supplement, if you have known liver disease, are taking hepatically-metabolised medications (particularly statins, which are also processed by the liver), or have been diagnosed with cirrhosis, please consult your physician before starting bergamot supplementation.
How long does bergamot take to affect liver health?
The Ferro 2020 RCT showed statistically significant liver fat reduction at 12 weeks. The 2018 NASH study showed accelerated liver recovery over a 10-week supplementation period. Based on the available evidence, a 12-week protocol is the minimum evaluation period for liver health goals. This contrasts with the 30-day results seen for cholesterol, which respond more quickly to bergamot’s lipid-lowering mechanisms.
References & Clinical Citations
1. Ferro Y, et al. Randomized Clinical Trial: Bergamot Citrus and Wild Cardoon Reduce Liver Steatosis and Body Weight in Non-diabetic Individuals Aged Over 50 Years. Front Endocrinol. 2020;11:494. doi:10.3389/fendo.2020.00494. PMC7431622
2. Parafati M, et al. Dramatic Suppression of Lipogenesis and No Increase in Beta-Oxidation Gene Expression Are among the Key Effects of Bergamot Flavonoids in Fatty Liver Disease. Antioxidants. 2024;13(7):766. doi:10.3390/antiox13070766. PMC11273501
3. Riillo C, et al. Bergamot Polyphenols Reduce Hepatic Lipogenesis While Boosting Autophagy and Short-Chain Fatty Acid Production in a Murine ‘Cafeteria’ Model of MASLD. Nutrients. 2025;17(23):3684. doi:10.3390/nu17233684. PMC12693897
4. Parafati M, et al. Bergamot Polyphenols Boost Therapeutic Effects of the Diet on Non-Alcoholic Steatohepatitis Induced by ‘Junk Food’: Evidence for Anti-Inflammatory Activity. Nutrients. 2018;10(11):1604. doi:10.3390/nu10111604. PMC6267059
5. Parafati M, et al. Bergamot polyphenol fraction prevents nonalcoholic fatty liver disease via stimulation of lipophagy in cafeteria diet-induced rat model of metabolic syndrome. Biochim Biophys Acta Mol Cell Biol Lipids. 2015;1851(10):1212-1222. doi:10.1016/j.bbalip.2015.05.006. PMID:26025327
6. Mollace V, et al. Hypolipemic and hypoglycaemic activity of bergamot polyphenols from animal models to human studies. Fitoterapia. 2011;82(3):309-316. doi:10.1016/j.fitote.2010.10.014
7. Capomolla AS, et al. Atherogenic Index Reduction and Weight Loss in Metabolic Syndrome Patients Treated with a Novel Pectin-Enriched Formulation of Bergamot Polyphenols. Nutrients. 2019;11(6):1271. doi:10.3390/nu11061271. PMC6627641
8. Huang MC, et al. Clinical application of bergamot (Citrus bergamia) for reducing high cholesterol and cardiovascular disease markers. Clin Ther. 2019;41(4):786-800. PMC6497409
This article is for educational purposes only and does not constitute medical advice. Individual results vary. Fatty liver disease requires medical diagnosis and management. If you have been diagnosed with liver disease, consult your physician before starting any supplement protocol. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Hassle-Free 365 Day Returns